Irrational use of medicines is a very complex problem. To address it, a full package of interventions to enhance the rational use of medicines must be put into effect. This must include educational, financial, regulatory and managerial strategies.

Efforts around key policy issues span the development of evidence-based clinical guidelines; set up and support of drugs and therapeutics committees; control of pharmaceutical promotion activities; promotion of the concept of essential medicines; continuing education of health providers; and consumer education.

The Access to Medicines and Health Technologies team supports countries to:

develop and put into action a strategy for the rational use of medicines, including antimicrobials stewardship programmes to contain antimicrobial resistance;

develop education programmes and other effective ways to promote the rational use of medicines by health workers and consumers; and

monitor and evaluate medicine use practices and interventions in health facilities.